ArticleCell death & disease2025

Preclinical evaluation of TIGIT as a target to enhance efficacy and mitigate T cell exhaustion in multiple myeloma following BCMA-CAR-T therapy.

Yuan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.